Merck's cholesterol pill gets US FDA approval

Merck's new cholesterol-lowering pill has received approval from the U.S. Food and Drug Administration (FDA). This was reported by Qazaqyia.kz citing Reuters.

The drug is designed to combat high cholesterol and has shown efficacy in clinical trials. FDA approval allows Merck to market the drug in the U.S. market.